Wednesday, February 18, 2015

Dance Biopharm Gets $9.5M

Brisbane, California-based Dance Biopharm, which is developing an inhaled insulin product to treat diabetes, said this morning that it has raised $9.5M in a funding round. The funding came in the form of convertible note and warrants. The company said the financing came from individuals and insitutional investors. Placement agent on the funding was SternAegis Ventures, through Aegis Capital Corp. Dance Biopharm is led by Dr. John Patton. The company says it has now raised a total of more than $33M in funding. More information »